A Study of Classical and Novel Markers of Disease in Multiple Sclerosis

Total Page:16

File Type:pdf, Size:1020Kb

A Study of Classical and Novel Markers of Disease in Multiple Sclerosis A Study of Classical and Novel Markers of Disease in Multiple Sclerosis By Ghaniah Z. Hassan-Smith A thesis submitted to the University of Birmingham for the degree of DOCTOR OF PHILOSOPHY (PhD) IN MEDICINE School of Infection and Immunity College of Medical and Dental Sciences University of Birmingham February 2015 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. Abstract Multiple sclerosis (MS) is a chronic inflammatory and degenerative condition of the Central Nervous System. Focal demyelinating lesions are its neuropathological hallmark, but widespread abnormalities found in otherwise “normal-appearing” tissue are better associated with disability outcomes. HMGB1 is a promiscuous sensor of cellular stress, acting as a link between sterile damage and innate immune mechanisms, with its extra-nuclear release producing diverse outcomes. We report novel findings of significantly increased HMGB1 expression throughout the brain tissue of MS vs. non-MS patients, particularly in macrophages/microglia and oligodendrocytes (OGD). In addition, cerebrospinal fluid HMGB1 levels were increased in early-stage MS patients compared to non-inflammatory control patients. HMGB1 stimulation in-vitro upregulates expression of its receptors in an OGD cell line, potentially propagating chronic inflammation. Expression of the Leucine Rich Repeat and Ig-domain-containing molecules, AMIGO-3 and LINGO-1 is also significantly increased by HMGB1 stimulation in-vitro. These molecules demonstrate particularly intense immunoreactivity in human brain tissue taken at biopsy, at an early disease stage. Thus, exogenous HMGB1 may influence neurodegenerative processes via AMIGO-3 and LINGO-1 and blocking their function could have therapeutic value. Increased expression of HMGB1 in OGD, however, may highlight endogenous neuroprotective mechanisms in response to an unknown trigger. ii For Zaki and Levizah iii Acknowledgements I extend sincere thanks to my supervisors, Dr Mike Douglas and Dr John Curnow, for their guidance and support over the period of study. The project would not have been possible without John’s involvement and I am deeply indebted to him for this, and his mentorship. I am also grateful to Mike who, along with Dr Gordon Mazibrada, created this research post and provided an excellent learning environment. In addition, I benefitted greatly from Mike’s breadth of knowledge in both scientific technique and clinical neurology and his respect for intellectual freedom was much appreciated. I am also most grateful to Dr Gordon Mazibrada and Dr John Woolmore for the excellent training in clinical MS. Gordon was incredibly supportive in all aspects of the project, in particular pursuing all educational opportunities. Heartfelt thanks also to Dr Martyn Carey and Dr Santhosh Nagaraju for their patience in dealing with my (many) neuropathological queries, despite ever-present clinical commitments. Thanks also to Alex Sinclair for her support and mentorship. Many thanks to the UK MS Brain Bank, Hammersmith Hospital and in particular to Professor Richard Reynolds and Dr. Djordje Gveric. Professor Margaret Esiri provided additional control tissue from the Thomas Willis Oxford Brain Collection, and I am most grateful to her for that. Many thanks also to Dr Peter Nightingale who was most helpful in reviewing statistical aspects of the project. Sincere thanks to Jane Steele’s fantastic team at the HBRC; I have immense respect for Souad Messahel and Johanna Dieguez Navas, who went out of their way to help with the project. In addition, thanks to Lindsay Durant, Matt Edmunds, Marie Voice, Robert iv Barry, Paul Tomlins and Seema Kalra from the Curnow Lab for their much- appreciated input on our collective ‘journey’. The project was only written up due to the help of a stellar supporting cast. Many thanks to my mother and father-in-law who were so generous with their time and help. My wonderful sister and her family offered unwavering support for which we are truly grateful. I would not have produced this document at all without the practical help of my parents and I sincerely thank them for this. More importantly, I thank them for their wisdom, kindness and inspiration, which have influenced me throughout my life. This thesis is wholly dedicated to Zaki and to Levizah, for being the light of our lives. v Publications arising from the thesis 1. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis. Hassan-Smith G, Durant L, Tsentemeidou A, Assi LK, Faint JM, Kalra S, Douglas MR, Curnow SJ. J Neuroimmunol. 2014 Nov 15;276(1-2):175-9. Conference proceedings 1. High-mobility Group Box 1 (HMGB1) Expression Is Increased In The Normal-appearing Brain Tissue Of Multiple Sclerosis (MS) Patients Vs. Controls. Ghaniah Z. Hassan-Smith et al. E-poster oral presentation at ACTRIMS/ ECTRIMS, Boston, September 2014 2. The expression pattern of High-mobility group box 1 (HMGB1) in the normal-appearing brain tissue of Multiple Sclerosis (MS) patients and controls. Ghaniah Z. Hassan-Smith, Martyn Carey, Santhosh Nagaraju, Souad Messahel, Gordon Mazibrada Ana-Marie Gonzalez, S. John Curnow and Michael R. Douglas. Association of British Neurologists, May 2014 vi Table of Contents Chapter 1. General Introduction ............................................................................................................... 1 vii Chapter 2. General Methods ...................................................................................................................... 58 2.1.1 MO3.13 cell line ................................................................................................................. 59 2.1.2 Cell proliferation ............................................................................................................... 60 2.1.3 Freezing down cells ......................................................................................................... 61 2.2.1 RNA quantification ........................................................................................................... 61 viii Chapter 3. Characterisation of early active lesional changes in a patient with clinically isolated syndrome, using classical and novel markers. ........................................ 72 ..................................................................... 77 3.4.2 Analysis ................................................................................................................................ 77 .......................................................................................................................... 78 .......................................... 80 ............................................................................................................................ 83 3.5.4 HMGB1 immunoreactivity is evident in peri-lesional regions ……….....……83 3.5.5 HMGB1 immunoreactivity persists into non-lesional region …...…………....86 3.5.6 Cortical regions distal to white matter lesions demonstrate specific HMGB1-positive expression patterns .................................................................................... 88 ix Chapter 4. Post-mortem study of HMGB1 expression patterns in MS and non-MS control patients…..………………………………………………………................………........105 4.1 Introduction….…………………………………………………………………………………….......…106 4.2 Aims……………………………………………………………………………………………..……….……108 4.3 Hypothesis.. .................................................................................................................................... 108 4.5 Statistical analysis……………………………………………………………………………………....116 4.6 Results………………………………………………………………………………………………………..117 4.6.1 HMGB1 expression is increased in active lesions from patients with progressive MS compared to non-MS controls……………………………………….……..117 4.6.2 HMGB1 expression is increased in non-lesional white matter compared to non-MS controls…………………………………………………….……………………………………118 4.6.3 HMGB1 expression is increased in non-lesional grey matter compared to non-MS controls………………………………………………………………………………………….121 4.6.4 HMGB1 expression is decreased in demyelinated vs. myelinated regions of the brain……………………………………………………………………………………………………..126 4.6.5 CD68-positive cells are increased in normal-appearing white matter (NAWM) and active lesional tissue blocks in MS patients……………………………...128 x 5.1 Introduction ................................................................................................................................... 145 5.1.1 CSF biomarkers in MS .................................................................................................... 146 5.5 Statistical analysis………………………………………………………………………………………158 xi Chapter 6. Exploration of the relationship between LRRIg molecules and HMGB1 in MS……….………………………………….…………………………………………....………………….…………….181 6.1 Introduction…..…………………………………………….………………………………….………….182 6.6.1 HMGB1 is expressed in the MO3.13 cell line………………….192 6.6.2 Stimulation of MO3.13
Recommended publications
  • Ilya Mark Scheinker: Controversial Neuroscientist and Refugee from National Socialist Europe
    HISTORICAL ARTICLE COPYRIGHT © 2016 THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES INC. Ilya Mark Scheinker: Controversial Neuroscientist and Refugee From National Socialist Europe Lawrence A. Zeidman, Matthias Georg Ziller, Michael Shevell ABSTRACT: Russian-born, Vienna-trained neurologist and neuropathologist Ilya Mark Scheinker collaborated with Josef Gerstmann and Ernst Sträussler in 1936 to describe the familial prion disorder now known as Gerstmann-Sträussler-Scheinker disease. Because of Nazi persecution following the annexation of Austria by Nazi Germany, Scheinker fled from Vienna to Paris, then after the German invasion of France, to New York. With the help of neurologist Tracy Putnam, Scheinker ended up at the University of Cincinnati, although his position was never guaranteed. He more than doubled his prior publications in America, and authored three landmark neuropathology textbooks. Despite his publications, he was denied tenure and had difficulty professionally in the Midwest because of prejudice against his European mannerisms. He moved back to New York for personal reasons in 1952, dying prematurely just 2 years later. Scheinker was twice uprooted, but persevered and eventually found some success as a refugee. RÉSUMÉ: Ilya Mark Scheinker, un spécialiste des neurosciences et un réfugié de l’Europe nationale-socialiste controversé. Ilya Mark Scheinker était né en Russie et il avait fait ses études de neurologie et de neuropathologie à Vienne. Il a collaboré avec Josef Gerstmann et Ernst Sträussler en 1936 pour décrire la maladie familiale à prions connue maintenant sous le nom de maladie de Gerstmann-Sträussler. En raison de la persécution Nazi qui a suivi l’annexion de l’Autriche par l’Allemagne nazie, Scheinker a fui Vienne pour s’établir à Paris puis à New-York après l’invasion de la France par l’Allemagne.
    [Show full text]
  • Stepping out to Support People with MS
    The Official Magazine of MS Australia – ACT/NSW/VIC www.msaustralia.org.au/actnswvic ISSN 1833-8941 Print Post Approved: Spring 2012 PP 255003/08108 Sandra The types of MS explained The benefits of Sully aquatic exercise Stepping out to support Spotlight on: people with MS Respite services New series: MS Awareness Emerging MS Month: treatments Highlights! www.facebook.com/MSAustralia http://twitter.com/MS_Australia www.youtube.com/MSSocietyAustralia Co-editors: Rebecca Kenyon & Sandra Helou Publisher: Multiple Sclerosis Limited ABN: 66 004 942 287 Website: www.msaustralia.org.au/actnswvic Frequency: Published quarterly in March, June, September, December Advertising enquiries: Tel: (02) 9646 0725, Fax: (02) 9643 1486, Email: [email protected] Design: Byssus, (02) 9482 5116, www.byssus.com.au Photographs: The stock images appearing in Intouch are sourced from Thinkstock.com Cover photography: Dan Freede Photography Printing: Webstar Print MS Australia – ACT/NSW/VIC ACT Gloria McKerrow House 117 Denison Street Deakin ACT 2600 Tel: (02) 6234 7000 Fax: (02) 6234 7099 12 NSW Studdy MS Centre 80 Betty Cuthbert Dr Lidcombe NSW 2141 Tel: (02) 9646 0600 Fax: (02) 9643 1486 Victoria The Nerve Centre 16 54 Railway Road Blackburn VIC 3130 Tel: (03) 9845 2700 Fax: (03) 9845 2777 11 MS ConnectTM (information and services): 1800 042 138 (free call) Regional offices: Visit www.msaustralia.org.au/actnswvic and click on ‘Contact Us’ Privacy Policy: Visit www.msaustralia.org.au/ actnswvic for our full policy document ISSN: 1833-8941 Disclaimer: Information and articles contained in Intouch are intended to provide useful and accurate information of a general nature for the reader but are not intended to be a substitute Take our Client Satisfaction Survey for legal or medical advice.
    [Show full text]
  • WASTE PAPER Colleaion a NEW HOME?
    . t v C » A s ^ c m n cr. xuHB 11. i n t t!40B TWELVE jKanrh^etrr Etintitts if^roUi D ll^ !l*l Pl6m 1 " i- there Is some danger thet flee, ■us to the stoeu auaagers. We w cosm ■ '" thrown helter-okelter e t nupOels, know they will M eay ooo- Green School 5509 About Town sMgkt egrout eU over churob Btruetlva ertUelem oCfered. Heard Along Main Street Uwan. Wild rise being eown In ARMY AND NAVY CLUB MMlt pleeoo n d i^ t net bo mgerdod “Besrfi AMag” really did hear t k i n a <Man «m koU thatr Gives Program C ky o f V V o f Chmrm And on Soma of Manehe$Ut^» Stdo SfrM fg, Too an the best thing. They b m tried the other day thet the new bus c a m «a H a f Uila afUmeoB Bt R with oets bofore, end It has not loop scbedulea from Hartford to tbt OBiiiiinrtrT- A buffet lunch Manchester Green vie Mein and proven popular. i i t e * ru g s m MANCHESTER, CONN., MONDAY, JI7NE 14, 1948 fFOURTBEN PAGES) P R IC tfO U ti trtn be eerred et three o’clock end A mother of two children celled » stope, were pussled by the deerth This buslneas o f adapting e crop Woodbridge etreeta. namely bueee Kindergarten and See> NEW SUPER VOL. Lxvn ., NO; u end epeghetti eupper et heeding out to the Green end re­ in to regloUr her obJecUon to of custonsere to n ktonUty has us pretty well ond Grade Pkeaent Children’s Dey progrems in the Let us look beck.
    [Show full text]
  • Otto Marburg (1874-1948) Verfasst Von Dr
    Vertriebene Psychiater und Neurologen (Teil 2) Otto Marburg (1874-1948) Verfasst von Dr. med. univ. Helmut Gröger im November 2019 Der Name Otto Marburg ist untrennbar mit dem Neurologischen Institut an der Universität Wien, das auch ein interakademisches Hirnforschungsinstitut war, verbunden. Er war dessen Vorstand von 1919 bis 1938, dem Jahr der Annexion Österreichs und des Inkrafttretens der „Nürnberger Rassengesetze“. Von diesen waren ebenso seine engsten Mitarbeiter Eugen Pollak (1891- 1953) und Leo Krainer (1907-1978) betroffen, die sich wie Marburg ins Exil retten konnten. Den früheren Mitarbeitern Ernst Adolf Spiegel (1895-1985), 1932 nach New York berufen, wurde 1938 in Abwesenheit die Habilitation an der Wiener Universität aberkannt, der 1933 emeritierte Alexander Spitzer (1868-1943) wurde in das KZ Abb. 1 Otto Marburg (Josephinum – Ethik, Sammlungen und Theresienstadt deportiert. Das weltweit anerkannte Geschichte der Medizin, MedUni Wien) Institut war kein interakademisches Institut mehr und wurde erst nach zweijähriger Vakanz nachbesetzt. Marburgs Werdegang Otto Marburg, 1874 in Römerstadt/Mähren (heute Rýmařov/Tschechische Republik) geboren, studierte an der Universität Wien Medizin, wo er 1899 promovierte. Bereits unmittelbar danach arbeitete er bis 1903 als unbesoldeter Assistent am Institut für Neurologie an der Universität Wien, das unter der Leitung Heinrich Obersteiners (1847-1922) stand. Er erweiterte seine Ausbildung an der Universitätsaugenklinik unter Ernst Fuchs (1851-1930) und an der Psychiatrisch- Neurologischen Universitätsklinik unter Wagner-Jauregg (1857-1940), außerdem in Berlin bei dem Physiologen Hermann Munk (1839-1912) und dem Neurologen Hermann Oppenheim (1858-1919) sowie bei dem Neurologen Pierre Marie (1853-1940) in Paris. Bereits 1905 an der Universität Wien für Neurologie habilitiert, wurde er 1906 I.
    [Show full text]
  • Trigeminal Neuralgia and Multiple Sclerosis: a Historical Perspective
    HISTORICAL REVIEW COPYRIGHT © 2017 THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES INC. Trigeminal Neuralgia and Multiple Sclerosis: A Historical Perspective David B. Burkholder, Peter J. Koehler, Christopher J. Boes ABSTRACT: Trigeminal neuralgia (TN) associated with multiple sclerosis (MS) was first described in Lehrbuch der Nervenkrankheiten für Ärzte und Studirende in 1894 by Hermann Oppenheim, including a pathologic description of trigeminal root entry zone demyelination. Early English-language translations in 1900 and 1904 did not so explicitly state this association compared with the German editions. The 1911 English-language translation described a more direct association. Other later descriptions were clinical with few pathologic reports, often referencing Oppenheim but citing the 1905 German or 1911 English editions of Lehrbuch. This discrepancy in part may be due to the translation differences of the original text. RÉSUMÉ: Perspective historique sur la névralgie du trijumeau et la sclérose en plaques. La névralgie du trijumeau (NT) associée à la sclérose en plaques (SP) a été décrite pour la première fois dans Lehrbuch der Nervenkrankheiten für Arzte und Studirende par Hermann Oppenheim en 1894, incluant une description anatomopathologique de la démyélinisation de la zone d’entrée dans la moelle épinière de la racine du trijumeau. Contrairement aux éditions allemandes, les premières traductions en anglais effectuées en 1900 et 1904 ne précisaient pas cette association. La traduction anglaise de 1911 décrivait une association plus directe. Les descriptions postérieures étaient des exposés cliniques contenant peu de rapports anatomopathologiques, se référant souvent à Oppenheim mais citant les éditions de Lehrbuch en allemand de 1905 ou en anglais de 1911. Cette disparité peut être en partie due à des différences dans la traduction du texte original.
    [Show full text]
  • Pathological Heterogeneity of Idiopathic Central Nervous System Inflammatory Demyelinating Disorders
    Pathological Heterogeneity of Idiopathic Central Nervous System Inflammatory Demyelinating Disorders C. Lucchinetti 1 Introduction . 20 2 Heterogeneity of Multiple Sclerosis White Matter Lesions . 21 2.1 Stages of Lesions . 21 2.2 MS Plaque Types . 22 2.3 Inflammation and Immune Effector Heterogeneity in MS . 24 2.4 Evidence for Immunopathogenic Heterogeneity in Multiple Sclerosis . 27 2.5 Immunopathologic Heterogeneity May Be Stage-Dependent . 30 3 Remyelination in MS . 31 4 The Clinicopathologic Spectrum of CNS Idiopathic Inflammatory Demyelinating Disorders . 32 4.1 Acute Disseminated Encephalomyelitis . 33 4.2 Marburg Variant of Acute MS . 34 4.3 Tumefactive MS . 35 4.4 Balo Concentric Sclerosis. 35 4.5 Neuromyelitis Optica . 36 Conclusions . 38 References . 38 Abstract The last decade has seen a resurgence of interest in MS neuropathology. This resurgence was partly fueled by the development of new molecular and histochemical tools to examine the MS lesion microscopically, as well as technological advances in neuroimaging, which permit a dynamic assessment of lesion formation and disease progression. The heterogeneous pathology of MS in relation to stage of lesion activity, phase of disease, and clinical course is discussed. Pathological studies reveal that the immune factors associated with multiple differ- ent effector mechanisms contribute to the inflammation, demyelination, and tissue injury observed in MS lesions. While many agree that pathological heterogeneity exists in white matter demyelinated lesions, it is uncertain whether these observa- tions are patient-dependent and reflect pathogenic heterogeneity or, alternatively, C. Lucchinetti Mayo Clinic College of Medicine , 200 First St. SW, Rochester, MN 55905, USA e-mail: [email protected] M.
    [Show full text]
  • Freud's Library a Comprehensive Catalogue Compiled and Edited By
    1 Freud’s Library A Comprehensive Catalogue Compiled and edited by J. Keith Davies and Gerhard Fichtner London: The Freud Museum Tübingen: edition diskord 2004 2 Contents 0. Note for the User 3 1. Abbreviations 4 2. Bibliography 6 3. Catalogue of Freud’s Library 8 4. Appendices (Samples of markings, underlinings and annotations) 540 4.1 Appendix 1 (Constans, L.: Oedipe, 1881) 541 4.2 Appendix 2 (Herzfeld, M.: Leonardo da Vinci, 1906) 545 4.3 Appendix 3 (Jensen, W.: Gradiva, 1903) 546 4.4 Appendix 4 (Lipps, T.: Komik und Humor, 1898) 549 4.5 Appendix 5 (Müller, J.: Handbuch der Physiologie, 2 v., 1834–40) 551 4.6 Appendix 6 (Philippson, L.: Family Bible, 1839) 553 4.7 Appendix 7 (Schreber, D. P.: Denkwürdigkeiten, 1903) 557 4.8 Appendix 8 (Smith, W. R.: Lectures on the religion, 1907) 564 4.9 Appendix 9 (Solmi, E.: Leonardo da Vinci, 1908) 573 4.10 Appendix 10 (Wittels, F.: Sigmund Freud, 1924) 573 5. Indices 1* 5.1 Index of Names 1* 5.2 Subject Index (english) 77* 5.3 Subject Index (german) 160* 5.4 Index of Publishers 242* 5.5 Index of Titles 268* 5.6 Index of Titles of Freud’s Works 363* 5.7 Index of Dedications 375* 5.8 Index of the Date of Dedications 388* 5.9 Index of Signatures 396* 5.10 Index of the Date of Signatures 399* 5.11 Index of Markings 405* 5.12 Index of Ex libris 406* 5.13 Index of Ownerships of the library’s parts 407* 5.14 Index of the Languages of Publications 418* 5.15 Index of Pictures on CD 429* 3 Note for the User The following catalogue unites those parts of Freud’s original library which were dispersed as a result of his emigration to London 1938.
    [Show full text]
  • Neuropathology of Multiple Sclerosis
    Neuropathology Article Neuropathology of Multiple Sclerosis ince the first clinico-pathological descriptions of almost 2 to 1. Incidence of MS varies by geographical loca- multiple sclerosis (MS), neuropathologists, neurolo- tion, the more industrialised countries showing the highest Sgists, immunologists, geneticists and scientists have figures. It remains unclear whether this altered incidence rep- worked together in an attempt to clarify the pathogenesis resents an environmental influence, genetic difference or sim- of this enigmatic disease. Multiple sclerosis is a complex ply is the result of variable surveillance. The natural history of condition and there is no consensus as to whether it rep- MS is usually characterised by progressive neurological dete- resents a single disease or a series of diseases with a com- rioration. Physical disability is the rule. A considerable num- mon final pathway. For this reason systematic pathologi- ber of affected individuals also experience cognitive dysfunc- cal analysis of brains affected by demyelination is still tion in the course of the disease although cognitive disability important to provide new insight into the pathogenesis of at onset is rare. Patients with MS exhibit different patterns of Federico Roncaroli qualified as a the disease. This review is the result of experience gained disease activity. About 80-85% have a relapsing–remitting Histopathologist in Italy and is now from examining brains donated by patients with MS to course and a considerable number develop secondary pro- Clinical Senior Lecturer in Neuro- the UK Multiple Sclerosis Tissue Bank (UKMSTB) at the gression with or without occasional relapses. About 10% of pathology at the Department of Neuropathology, Imperial College Imperial College of London.
    [Show full text]
  • An Influential Neurologist from New York M
    Review Neurosciences and History 2020; 8(1): 12-28 Louis Casamajor (1881-1962), an influential neurologist from New York M. Marco Igual Neurologist. Hospital Parc Taulí, Sabadell, Barcelona, Spain ABSTRACT For more than four decades, Louis Casamajor (1881-1962) was one of the most active specialists in neurology and psychiatry in New York City and the United Sates. He was born in Brooklyn to a family of French-Cuban origin, and worked throughout his career in connection with Columbia University and the Neurological Institute of New York. Casamajor, a neurologist and psychiatrist who trained in Europe as a neuropathologist under Otto Marburg and Alois Alzheimer, was one of the founders of American paediatric neurology; despite this background, he has largely been overlooked in history. In the United States, he was a pioneer in the description of manganese poisoning, compressive myelopathy of vertebral origin, and Guillain-Barré syndrome. He also introduced the Wassermann test and was one of the first supporters of psychoanalysis. Casamajor had a special interest in the development of electroencephalography and pneumoencephalography in children. He was sociable and a prolific writer, a member of many societies, and one of the founders and directors of the American Board of Psychiatry and Neurology. KEYWORDS Columbia University, Louis Casamajor, Neurological Institute of New York, neurologist, neuropathologist, paediatric neurologist, psychiatrist A nice, sweet, kindly old giant of a man who could He was also one of the founders of American paediatric hold an infant in the palm of one hand. His name neurology. was Louis Casamajor and among other things, he had a falsetto voice and his famous line would be – Casamajor was born into a family of French-Cuban he would hold a baby in one hand and look at it and origin, settled in Brooklyn; like many of his contemporary say, “This is a silly baby.” He was always right.
    [Show full text]
  • Past ABPN Giants in Neurology
    ABPN 75th Anniversary Celebration Giants of Neurology Mark L Dyken, MD Professor Emeritus of Neurology Indiana University Medical School September 26, 2009 ABPN “NEUROLOGY GIANTS” (American Neurological Association & American Academy of Neurology” ANA Presidents 1. Lewis J. Pollock 1942 2. Edwin G. Zabriskie 1944 3. Henry W. Woltman 1950 4. Hans H. Reese 1953 5. Roland P . Mackay 1954 6. Percival Bailey 1955 7. Johannes M. Nielsen 1956 8. H. Houston Merritt 1957 AAN Presidents 9. Bernard J. Alpers 1959 1. Abe B. Baker* 1948-1951 10.RllDJRussell DeJong 1965 2. FiMFtFrancis M. Forster 1957-1959 11.Adolph L. Sahs 1968 3. Augustus S. Rose* 1959-1961 12.Augustus S. Rose 1969 4. Adolph L. Sahs* 1961-1963 13.Melvin D. Yahr 1970 5. Sidney Carter 1969-1971 14.Abe B. Baker 1971 *Also ANA ANA Vice Presidents 1. Louis Casamajor 1939 2. Frederich P. Moersch 1952 3. Alphonse Vonderahe 1955 4. Paul I. Yakovlev 1959 5. Charles Rupp 1960 6. Knox Finley 1963 7. Alexander T. Ross 1967 •M.D. 1906 College of Physicians and Surgeons •1909 -1948 New York Neurological Institute . Assistant Attending to Professor Emeritus. •Early interest in Child Neurology followed Bernard Sachs and was followed by Sidney Carter and then Darryl DeVivo •President of several psychiatric societies, but defensive about N before P in ABPN, •“Neurologists, you know, have much more reverence for the alphabet than psychiatrists have.” •"Personally I don't give a damn …” One of most colorful and the most controversial of all ABPN directors. ((yThe Lobotomist: by Jack El-Hai , Last Resort: Psychosurgery and Limits of Medicine by Pressman JD.
    [Show full text]
  • Giants of Neurology
    Giants of Neurology Mark L Dyken, MD Professor Emeritus of Neurology Indiana University Medical School Prepared for and partially presented at the ABPN 75th Anniversary Celebration on September 26, 2009 Contents Introduction 3 The Founding Fathers 4 Louis Casamajor 1934-1942 5 Walter Jackson Freeman 1934-1948 6 Jeffrey Allen Jackson 1934-1938 7 Lewis John Pollock 1934-1937 8 Edwin Garvin Zabriskie 1934-1939 8 Lloyd Hiram Ziegler 1934-1945 9 1938-1949 10 Board of Directors 1948 10 Henry William Woltman 1938-1941 11 Tracy Jackson Putnam 1940-1943 12 Hans Heinrich Reese 1940-1947 13 Johannes Maagaard Nielsen 1941-1942 14 John Charnley McKinley 1942-1945 15 Percival Bailey 1943-1946 15 Hiram Houston Merritt 1943-1950 17 Alphonse Ralph Vonderahe 1943-1948 18 Roland Parks Mackay 1946-1943 19 Bernard Jacob Alpers 1948-1955 20 Frederick P. Moersch 1949-1956 20 The 1950s 22 Board of Directors 1952 22 Russell Nelson DeJong 1951-1958, 1971-1972 23 Paul Ivan Yakovlev 1951-1958 24 Francis M. Forster 1953-1960 25 Knox Hendeson Finley 1954-1961 26 Lee McKendree Eaton 1957-1958 27 Abraham Bert Baker 1959-1966 28 Sidney Carter 1959-1966 29 Alexander Treloar Ross 1959-1964 30 Board of Directors 1958 32 The 1960s On 33 Adolph Louis Sahs 1960-1967 33 Board of Directors 1962 34 Augustus Steele Rose 1961-1968 35 Charles Rupp 1962-1969 36 Arnold Phineas Friedman 196-1972 37 David Barrett Clark 1969-1976 37 Board of Directors 1969 39 Thomas Richards Johns, II 1975-1982 40 Melvin David Yahr 1975-1082 41 John Robert Calverley 1977-1984 42 Leonard Berg 1978-1985 42 Board of Directors 1977 44 Acknowledgments 45 Photographs 45 2 INTRODUCTION: As part of the celebration of the 75th Anniversary of the American Board of Psychiatry and Neurology, the directors decided that those deceased past directors who were “giants” in Psychiatry and Neurology be recognized in formal presentations that could be included in a monograph.
    [Show full text]
  • Downloads/9Zf2tk7klb4k8ccsskgswoso8/ Candidates’ Biographical Details Mem Articlesofassoc.Pdf) and Statements of Their Goals and Gustavo C
    VOL. 28 • NO. 2 • JUNE 2013 THE OFFICIAL NEWSLETTER OF THE WORLD FEDERATION OF NEUROLOGY World Congress of Neurology: Vienna in September INSIDE BY DONNA BERGEN, MD features he 21st World Congress of Neurology WFN Elections 2013 (WCN 2013) will be held Sept. 21-26 Nominating committee recommendations in Vienna, in conjunction with the T and candidate statements. PAGE 4 European Federation of Neurological Societies and the Austrian Society of The International Working Neurology. The theme of the congress will Group of Young Neurologists be Neurology in the Age of Globalization. and Trainees (IWGYNT) The first World Congress in Vienna IWGYNT seeks to represent the was the eighth in 1965, with Sir Gordon interests of junior neurologists within Holmes among the honorary presidents. the World Federation of Neurology The president was Hans Hoff, the vice pres- (WFN). PAGE 12 ident was Franz Seifelberger, the scientific Building Local secretary was Helmut Tschabitscher and Networks of Expertise the general secretary was Franz Gersten- Establishing international scientific brandt, who also will take part in the 21st relations among physicians and basic World Congress of Neurology. The presi- scientists, holding teaching courses and dent of the World Congress of Neurology providing research groups a common Vienna 2013 is Professor Eduard Auff, from basis to work together. PAGE 12 the Austrian Neurological Society. The World Congress of Neurology in The success of Vienna is likely to be particularly well at- Haoua Ousseini Sidibe, MD tended, since both the European Federation This is the story of the first female P lan your travel now to Vienna in the fall for World Congress of Neurology Sept.
    [Show full text]